2026-01-31
Chinese Female PhD’s Portable MRI Wins World’s Only Top Award
The 2025 Prince-Meany Translational Science Award winner — a young Chinese scientist received the award for developing a portable MRI device that reduces costs by 90%, set to transform global medical imaging.
2026-01-13
China’s 1st Next-Gen TRK Inhibitor Approved: 90% Tumor Shrinkage
China’s NMPA approved the first next-generation pan-cancer TRK inhibitor, demonstrating 90% tumor shrinkage in NTRK fusion-positive solid tumor patients.
2026-01-12
China-Backed Breakthrough: New Drug for HER2-Mutant Lung Cancer Approved
Innovative oral drug Zongertinib targeting HER2 mutations was officially approved, providing a new targeted therapy option for HER2-mutant NSCLC patients.
2025-12-20
China CAR-T Breakthrough: Coverage Expanded to All Major Hematologic Cancers
China’s CAR-T cell therapy products have been successively approved, covering leukemia, lymphoma, myeloma and other major hematologic cancers. China is now the most active country in CAR-T clinical trials globally.
2025-12-05
China AI Diagnostic System Receives FDA Breakthrough Device Designation
An AI-assisted pancreatic cancer early screening system developed by a Chinese tech company received FDA Breakthrough Device Designation — the first such designation for a Chinese AI medical device.
2025-11-18
WHO Officially Includes Traditional Chinese Medicine in Global Medical Guidelines
The WHO officially included Traditional Chinese Medicine in ICD-11, marking a historic elevation of TCM’s status in the global medical system.